Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P N Dannon

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Clinical Neuropharmacology|October 23, 1997
Vitamin E treatment in tardive dystoniaP N Dannon, L Grunhaus, I Iancu, et al.
Depression and Anxiety|May 11, 2010
Deep TMS in a resistant major depressive disorder: a brief reportO Rosenberg, N Shoenfeld, A Zangen, et al.
CNS Drugs|July 21, 2001
Kleptomania: diagnosis and treatment optionsR Durst, G Katz, A Teitelbaum, et al.
Clinical Neuropharmacology|April 1, 1997
Emergence of kleptomania during treatment for depression with serotonin selective reuptake inhibitorsS Kindler, P N Dannon, I Iancu, et al.
Psychopharmacology|June 15, 1999
Resolution of treatment-refractory depression with naltrexone augmentation of paroxetine--a case reportR Amiaz, O Stein, P N Dannon, et al.
Clinical Neuropharmacology|February 1, 1995
Nightmares related to fluoxetine treatmentE Lepkifker, P N Dannon, I Iancu, et al.
International Journal of Psychiatry in Clinical Practice|June 14, 2014
Transcranial magnetic stimulation is effective in the treatment of relapse of depressionP N Dannon, S Schreiber, O T Dolberg, et al.
The Journal of ECT|June 22, 2001
Coadministration of melatonin and fluoxetine does not improve the 3-month outcome following ECTL Grunhaus, S Hirschman, O T Dolberg, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 1, 2011
Effectiveness of a second deep TMS in depression: a brief reportO Rosenberg, M Isserles, Y Levkovitz, et al.
Bipolar Disorders|December 14, 2002
Response to ECT in major depression: are there differences between unipolar and bipolar depression?L Grunhaus, S Schreiber, O T Dolberg, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Clinical Neuropharmacology|October 23, 1997
Vitamin E treatment in tardive dystoniaP N Dannon, L Grunhaus, I Iancu, et al.
Depression and Anxiety|May 11, 2010
Deep TMS in a resistant major depressive disorder: a brief reportO Rosenberg, N Shoenfeld, A Zangen, et al.
CNS Drugs|July 21, 2001
Kleptomania: diagnosis and treatment optionsR Durst, G Katz, A Teitelbaum, et al.
Clinical Neuropharmacology|April 1, 1997
Emergence of kleptomania during treatment for depression with serotonin selective reuptake inhibitorsS Kindler, P N Dannon, I Iancu, et al.
Psychopharmacology|June 15, 1999
Resolution of treatment-refractory depression with naltrexone augmentation of paroxetine--a case reportR Amiaz, O Stein, P N Dannon, et al.
Clinical Neuropharmacology|February 1, 1995
Nightmares related to fluoxetine treatmentE Lepkifker, P N Dannon, I Iancu, et al.
International Journal of Psychiatry in Clinical Practice|June 14, 2014
Transcranial magnetic stimulation is effective in the treatment of relapse of depressionP N Dannon, S Schreiber, O T Dolberg, et al.
The Journal of ECT|June 22, 2001
Coadministration of melatonin and fluoxetine does not improve the 3-month outcome following ECTL Grunhaus, S Hirschman, O T Dolberg, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 1, 2011
Effectiveness of a second deep TMS in depression: a brief reportO Rosenberg, M Isserles, Y Levkovitz, et al.
Bipolar Disorders|December 14, 2002
Response to ECT in major depression: are there differences between unipolar and bipolar depression?L Grunhaus, S Schreiber, O T Dolberg, et al.
Pageof 4